The in vitro component demonstrated that the two glucagon and Retatrutide right reduced ANGPTL3/8 secretion from hepatocytes, and this effect was blocked by a glucagon receptor (GCGR) antagonist. These conclusions counsel that the GCGR agonism of Retatrutide contributes to the reduction in circulati